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L3T4+ T cells promoting susceptibility to murine 
cutaneous leishmaniasis express the surface marker 
Ly-24 (Pg{i-1)* 
In a murine model of cutaneous leishmaniasis, the importance of T cell-dependent 
immunity has been documented by the susceptibility to parasite infection of athymic 
nude mice of both genetically resistant and genetically susceptible strains. T lympho-
cytes from uninfected mice have the capacity to promote resistance to Leishmania 
major infection in nude recipients, whereas T cells from mice chronically infected with 
Lo majornot only fall to mediate protection, but totally abrogate the host-protective 
effect of normal mouse lymphocyteso Both these effects are mediated by T cells which 
have the phenotype L3T4+Ly-2-o To discriminate between the two activities, we have 
tried toseparate the L3T4+ population on the basis of additional cell surface markers 
and we have found that peripheral L3T4+ lymphocytes could be subdivided according 
to their expression of the Ly-24 (Pgp-1) surface markero In adoptive transfer experi-
ments, both the Ly-24+ and the Ly-24- subset of L3T4+ cells from uninfected mice 
bad the capacity to mediate resistance to infection with L. major. However, disease-
promoting activity was only found in the L3T4+Ly-24+ and not in the L3T4+Ly-24-
subset of cells from mice with chronic cutaneous diseaseo Moreover, Ly-24 expression 
was strongly increased in lymphocytes from chronically infected mice and in vitro 
limiting dilution analysis confirmed that the vast majority of L. major-reactive T cells 
was L3T4+Ly-24+ 0 In genetically susceptible mice with chronic cutaneous leish-
maniasis, Ly-24 therefore appears to be a marker for lymphocytes with the capacity to 
abrogate resistance to disease, these cells being activated and expanding in the course 
of progressive Lo major infectiono Ly-24 expression is a useful tool for phenotypic 
identification and selective enrichment of antigen-activated and possibly memory 
T cellso It may facilitate the isolation of L. major-specific T cell clones with defined 
activitieso 
1 Introduction 
Human cutaneous leishmaniasis is caused by the protozoan 
parasite Leishmania major and the spectrum of clinical man-
ifestations seen in humans can be reproduced experimentally 
in miceo The outcome of the disease in mice depends on the 
strain of animals usedo In the course of infection L. major 
promastigotes invade host macrophages, inside which they 
transform to amastigotes and expando Mice of genetically 
resistant inbred strains (eogo C57BU6) can control the infec-
tion with lesions healing completely, whereas genetically sus-
ceptible mice (eogo, BALB/c) develop a progressive disease 
[I 6815] 
• This work was supported by tbe Australian National Healtb and 
Medical Research Council, the RockefeUer Foundation Great Neg-
lected Diseases Program and the Leishmaniasis Component of the 
UNDP/World Bank/WHO Special Programme for Research and 
Training in Tropical Diseaseso 
0 Supported by the Deutsche Forschungsgemeinschaft. 
Correspondence: Heidrun Moll, Institut für Klinische Mikrobiologie 
und Infektionsbygiene, Universität Erlangen, Wassertunnstro 3, 
D-8520 Erlangen, FRG 
Abbrevfations: Con A SN: Supematant from concanavalin A-stimu-
lated rat spieen ceUs CTLL: Cloned cytotoxic T lymphocyte 
line FACS: Fluorescence-activated ceU sorter mc: Fluorescein 
isotbiocyanate IFN-y: Interferon-y n.: Interleukin LD: Limiting 
dilution LNC: Lymph node ceU(s) mAb: Monoclonal antibody(ies) 
MBC: Major histocompatibility complex PE-Av: Phycoerythrin-con-
jugated avidin SC: Spleen cell(s) SN: Supernalant T11: T helper 
(lymphocyte) 
© VCH Verlagsgesellschaft mbH, D-6940 Weinheim, 1989 
with Iethai outcomeo However, athymic nude mice of both 
healer and nonhealer genotypes are highly susceptible [1], 
demonstrating the significance of T cell-dependent immunity 
in resistance to cutaneous disease [2-4)0 Early studies showed 
that T lymphocytes from uninfected mice have the capacity to 
promote . resistance to L. major infection in nude recipients, 
whereas T cells from mice chronically infected with L. major 
generally not only fail to mediate protection, but can totally 
abrogate the host-protective effect of normal mouse lympho-
cytes [5]o T cells from uninfected mice with resistance-promot-
ing activity and T cells from chronically infected mice with 
disease-promoting activity both express the L3T4+Ly-2-
phenotypeo 
Previous studies have indicated functional heterogeneity of 
L3T4 + cells, showing that antigen-specific and major his-
tocompatibility complex (MHC) class 11-restricted cloned 
murine T helper (Tb) cells of this phenotype give rise to differ-
ential pattems of lymphokine production [6, 7)o The L3T4+ 
T cell clones were classified into two categories {7], designated 
Tßl, producing interleukin (IL) 2 and interferon-y (IFN-y), 
and TH2, produclog IL 4and IL 5. The different roles of these 
T cell types in the pathogenesis of L. major infections was 
suggested by the recent studies of Locksley et al. [8], which 
showed lymph node cells (LNC) from ·healer mice to be high 
producers of IFN-y and those from nonhealer mice to release 
only minimal amounts of the same lymphokineo On the other 
band, only lymphoid cells from nonhealer mice contained IL 4 
mRNAo 
Patterns of lymphokine production allow the identification of 
functionally distinct L3T4 + cellso However, it would be par-
ticularly useful tobe able to distinguish L3T4+ subsets on the 
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basis of surface antigen expression, since this would allow their 
separation and functional characterization. Furthermore, it 
could facilitate the isolation of T cell clones with defined 
activities. During a screening for lymphocyte surface markers 
which might subdivide the L3T4+ population, we observed 
that a monoclonal antibody (mAb) directed against Ly-24 
(Pgp-1), previously shown tobe expressed by a variety of cell 
types such as immature thymocytes and myeloid cells (9], 
could identify a subset of peripheral L3T4 + lymphocytes. At 
the same time, this finding was reported by others [10, 11] who 
showed that Ly-24 expression was induced by mitogen or anti-
gen Stimulation suggesting that Ly-24 is a T cell activation 
antigen .. , 
In th~ pre~nt study, L3T4+ cells expressing or lacking the Ly-
24 alloantigen were separated by sorting in a fluorescence-
activated cell sorter (FACS) and were examined for their abil-
ity to induce disease resistance, or abrogation of resistance, in 
nude mice infected with L. major. It was demonstrated that 
both L3T4+Ly-24+ and L3T4+Ly-24- cells could mediate 
resistance to infection. On the other band, only L3T4+Ly-24+ 
but not L3T4+Ly-24- cells promoted permissiveness to dis-
ease. Furthermore, the proportionofT cells expressing Ly-24 
~as highly increased in mice chronically infected with L. ma-
JOT. The data are consistent with the notion that Ly-24 is a 
marker for disease-promoting T cells that have been activated 
in the. course of L. major infection. Lymphocyte selection 
according to Ly-24 expression may provide an important tool 
for the isolation of L. major-specific T cell clones. 
2 Materials and metbods 
2.1 Mice 
Fernale mice of the inbred strains BALB/c and C57BL/6 were 
used at an age of 7 to 10 weeks; female congenitally athymic 
BALB/c.nulnu (nude) mice were 6 to 8 weeks of age at the 
com.mencement of experiments. All mice were bred under 
specific patbogen-free conditions at The Walterand Eliza Hall 
Institute. of .Medical Research but, during experimentation, 
were mamtamed under conventional conditions in an isolation 
facility. 
2.2 mAb and fluorescence reagents 
The . mAb were prepared from supematants (SN) of 
hybndomas grown at the Hall Institute, purified and conju-
gated where noted in this Iabaratory. Antibodies directed 
against Ly-24 (Pgp-1), from the hybridoma IM7.8.1 (12], Mac-
1, from the hybridoma M1nO [13), and Ly-2.2, from the 
by~rido~a H02/2 [14J were used as culture SN. Anti-Thy-1.2 
antibod1es, from hybndoma F7D5 [15], were kindly provided 
by Dr. Phil Lake. Anti-L3T4 antibodies, from the hybridoma 
GK1.5 (16], and anti-Ly-2 antibodies, from the hybridoma 
53-6.7 [17), were used as biotin-conjugated purified protein. 
A ßuorescein isothiocyanate (FITC)-conjugated rabbit anti-
mause antibody (Silenus Laboratories, Melboume Aus-~~), CT<?ss-reacting with rat immunoglobulin (Ig), and 
avulin conJugated to phycoerythrin (PE-Av; Becton Dickin-
son, Mountain View, CA) were used as second-stage reagents 
for Ouorescence staining. Rat Ig, for blocking residual second-
stage Ig reagents, was purchased from Miles Laboratories, 
Elkhart, IN. 
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Z.3 Parasltes and prepantion of antlgen 
The cloned virulent L. major parasite line V121 was produced 
from the human isolate LRC-L137 [18] and maintained by 
passagein BALB/c mice. Promastigotes were grown in vitro in 
bloodlagar cultures [1). Stationary-phase promastigotes were 
washed and 2 x Hf organisms were injected in a volume of 
50 J1l intradermally (i.d.) on the dorsum of the mouse close to 
the base of the tail. 
Antigen preparations for immunization and in vitro Stimula-
tion of lymphocytes were generated by UV -irradiation 
(254 nm) of L. major promastigotes for 20 min. This treat-
ment resulted in killing of the parasites, as judged by staining 
with ethidium bromide/acridine orange [1 J.Lglml in phosphate-
buffered saline (PBS)] and their failure to infect mice, but did 
not cause disruption of the organisms. This preparation was 
found to be superior to parasites killed by freezing and thaw-
ing for use for in vitro Stimulation of lymphocytes. 
Z.4 Immunization and ceU preparations 
Immunization of mice with L. major promastigotes was per-
formed by i.v. injection with tbree weekly doses of 2 x 107 
UV-irradiated promastigotes in 0.1 mf CJf PBS. Spleen cell 
(SC) suspensions were prepared 5-7 days after the last 
immunizatiori.äild T cells were obtained by nylon wool purifi-
cation [19] for use in in vitro cultUres. For reconstitution of 
nude mice, SC andlor mesenteric, inguinal and axillary LNC 
were obtained from normal mice or from mice chronically 
infected with L. major parasites (i.e., 60-100 days after infec-
tion). Lymphocyte subpopulations were purified by fluores-
~enc~ staining and subsequent cell sorting and were injected 
t. p. m a volume of 0.2 ml. 
2.5 Fluorescence stainlng and cell sorting 
The basic procedures have been described in detail [201. For 
phenotype analysis using two-color cytometry, 3 x 10~ lym-
phocytes in 30 J1} were stained sequentially with anti-Ly-24 
(Pgp-1) antibodies, FITC-conjugated anti-Ig antibodies and 
rat Ig to block any free binding site on the latter reagent, 
followed by either biotin-labeled anti-Ly-2 or anti-L3T4 anti-
hodies and PE-Av. Propidium iodide (0.5 Jlg/ml; Calbiochem, 
La Jolla, CA) was included in the final wash to stain dead cells 
and faci~itate their exclusion from flow cytometric analysis. 
Cell sorting for LD cultures was performed after staining lym-
phocytes (10S/ml) as described above. Cell sorting for adoptive 
tra~sfer experi.men~s was based on a one-color staining with 
anti-Ly-24 anttbodies followed by FITC-conjugated anti-Ig. 
No propidium iodide was included when the sorted cells were 
prepared for nude mouse reconstitution. All reagents were 
used at near-saturating conditions and the reaction time was 20 
min on ice for each step in siliconized glass tubes. The fluores-
ce.ncc::-activated cell sorter was a modified FACS li (Becton 
Dtckmson, Sunnyvale, CA). Details of the instrument and its 
use in ~o-color (red and green fluorescence) sorting have 
been giVen elsewhere [20]. Dead cells and debris were 
excluded from analysis and sorting on the basis of both low-
angle light scatter and the strong red fluorescence from prop-
idium iodide staining. 
Since Ly-24 expression by peripheralT cells was continuous 
rather than bimodal, an appropriate control sample, stained 
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with the second-stage antibodies alone, was used to determine 
the cut-off point between Ly-24- and Ly-24+ cells for each 
sorting procedure. The sorting windows were set to collect 
negative (see Fig. 1) and positive cells leaving a gap of20 to 25 
channels between the sorting windows. The purity of the 
sorted Subpopulations was controlled by subsequent re-analy-
sis in the FACS. 
2.6 Cytotoxic procedures 
Single-cell suspensions of SC or spienie T cells at a concentra-
tion of 107/ml were incubated for 40 min on ice with either anti-
Thy-1.2 (for preparation ofT cell-depleted stimulator cells) or 
anti-Ly-2.2 (for preparation of L3T4+ respander cells) anti-
hodies and for another 20 min at 37 oc with rabbit comple-
ment in a final dilution of 1 : 15 as described [20). Allowance 
was made for the warm-up time in the second-incubation 
period, and DNase (50 JJ.g/ml) was added to reduce clumping 
problems and improve recovery. 
2. 7 LD analysis 
SpienieT ceUs, L3T4+ T cells, or sorted L3T4+ T cell subsets 
from L. major-immunized mice were cultured in limiting num-
ben in round-bottom microtiter wells (Linbro, Flow 
Laboratories, North Ryde, N.S.W., Australia) with 2 x 105 
irradiated (3000 rad) syngeneic spieen accessory cells from 
normal mice in 0.2 ml of a modified RPMI culture medium 
(supplemented with 32 mM Hepes, 10-4 M 2-mercaptoethanol 
and 10% fetal calf serum) containing 15% of a SN from con-
canavalin A-stimulated rat SC cultures (Con ASN) as a source 
of IL 2. For each T cell concentration ranging from lo4 to 150 
cellslwell, replicates of 24 wells were set up in the absence or in 
the presence of 2 x lOS UV -irradiated L. major promastigotes 
as a source of antigen. After 7 days of incubation (37 oc, 10% 
C02}, microcultures were washed three times to remove Con-
ASN and were restimulated by adding 2 x lOS irradiated 
(3000 rad) T cell-depleted syngeneic SC in the absence or 
presence of antigen (2 x lOS UV -irradiated L. major promas-
tigotes), respectively, in 0.2 ml culture medium. After 24 h of 
incubation, 150 JAl of SN was removed for determination of 
IL 2 and IL 3 lymphokine activity. Coltures containing T cells 
and accessory cells but not antigen were used as controls for 
each T cell concentration. Antigen-stimulated microcultures 
were scored as positive when the values of lymphokine activity 
exceeded the arithmetic mean of the control wells by more 
than 3 SD. Minimal estimates of the precunor frequency for 
each activity were obtained by the maximum likelihood 
method from the Poisson distribution relationship between the 
number of responding cells and the logarithm of the fraction of 
negative cultures (21]. 
2.8 Assays for n. 2 and IL 3 activity 
Microculture SN was tested for IL 2 or IL 3 activity by incuba-
tion with the cloned IL 2-dependent cytotoxic T lymphocyte 
line (crLL) [22] ortheIL 3-dependent hematopoietic cellline 
32D [23, 24), respectively. The cell lines were kindly provided 
by Dr. Anne Kelso of this Institute. Of SN 50 JAl were cultured 
with 4 x lQ-1 CI'LL cells or 2 x lQ-1320 cells in a total of 100 JAl 
RPMI 1640 culture medium in ßat-bottom microwells (Unbro, 
Flow Laboratories). After 20 h (CfLL assay) or 44 h (32D 
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assay), 1 J.LCi = 37 kBq [3H]thymidine was added forafurther 
4-5 h. Cells were harvested onto filter paper strips using an 
automated cell harvester and counted in a Jiquid scintiUation 
ß-counter. 
2.9 Assessment of leslons 
Lesion scores were detenD.ined at regular intervals according 
to the following system: 0 = no lesion or healed scar; 1 = small 
swelling (up to 5 mm in average diameter); 2 = large swelling 
(more than 5 mm in average diameter) or open lesion of less 
than 5 mm in average diameter; 3 = open lesion of 5-10 mm in 
diameter; 4 = open lesion greater than 10 mm in diameter and/ 
or obvious metastases. Data are expressed as the arithmetic 
mean of the lesion scores for the groups of four to six mice, 
and the number of mice with lesions relative to the total 
number of mice per group as weil as standard errors are given 
for the last time point of each experiment. 
3 Results 
3.1 Expression of the Ly-24 antigen on peripheral L3T4+ 
T ceßs 
Two-color flow cytometry demonstrated that peripheral 
L3T4 + lymphocytes could be phenotypically subdivided 
according to expression of the Ly-24 surface marker. In nor-
mal BALB/c mice, 72% of L3T4+ LNC were Ly-24+ and 28% 
were Ly-24- (Fig. 1). This distribution of Ly-24 expression 
was very similar for SC of the same strain. SC and LNC from 
normal C57BU6 mice can also be separated into a L3T4+ Ly-
24- and a L3T4+ Ly-24+ subset, the proportion ofLy-24+ cells 
being lower than in BALB/c mice (data not shown). These 
findings are in agreement with recent reports by others show-
ing that a minor population of L3T4+ LNC and SC expresses 
Ly-24 in C57BU6 mice [10, 25], whereas in BALB/c mice, the 
majority of peripheral L3T4+ cells is Ly-24+ [25]. 
Green Fluorescence ( Ly-24) 
Figure 1. Subdivision of L3T4+ lymphocytes according to Ly-24 
expression. LNC from normal BALB/c mice were sequeotially treated 
with anti-Ly-24 antibodies, flTC-conjugated anti-mouse antibodies, 
biotin-conjugated anti-L3T4 antibodies and PE-Av and were sub-
jected to two-color fluorescence analysis in the FACS. As control, 
cells were treated only with anti-L3T4 antibodies and the second-stage 
reagents. The profiles show the green ßuorescence (Ly-24 expression) 
of L3T4+ (red positive) cells stained in the presence (solid line) or 
absence (dotted line) of anti-Ly-24 antibodies. The dashed line indi-
cates the upper window used for sorting negative ceUs. 
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In the course of screening for lymphocyte surface markers 
wbich might subdivide peripheral L3T4+ lymphocytes, we also 
identified two other antigens that define subsets of these lym-
phocytes in untreated mice (data not shown). These were the 
alloantigen Ly-6 (26) and a lymphocyte homing molecule 
defined by the antibody MEL-14 [27]. 
3.2 Reconstitution of BALB/c nude mice witb Ly-24+ cells or 
Ly-24- cells from normal BALB/c mice 
Wehave previously shown that small numbers (Hf to 107) of 
T lymphocytes from normal BALB/c mice have the capacity to 
induce resistance to infection with L. major parasites in 
syngeneic athymic nude mouse recipients and that these resis-
tance-promoting T cells belong to the L3T4+ subpopulation (5, 
28). To examine wbether the host-protective activity resides in 
the Ly-24+ or the Ly-24- subset of normal mouse lympho-
cytes, we separated these cells in the FACS and used them for 
adoptive transfer into nude mice. 
For the selection of lymphocyte subsets, LNC from uninfected 
euthymic BALB/c mice were stained with anti-Ly-24 and anti-
Mac-1 antibodies followed by FITC-conjugated anti-Ig. This 
staining procedure separated the brigbtly fluoresceinating B 
cells and macrophages from the less brightly stained Ly-24 + 
T cells and the fluorescence-negative Ly-24- population. 
Unseparated lymphocytes (106), or the sorted Ly-24+ and 
Ly-24- lymphocyte subsets, in numbers equivalent to their 
original proportion in 106 unseparated LNC, were injected 
into BALB/c nude mice that were subsequently challenged 
with 2 x 1W L. major promastigotes. As a control for the 
infectivity of the parasites, another group of mice received 
promastigotes in the absence of lymphocytes. The course of 
cutaneous lesion development (Fig. 2) shows that botb Ly-24+ 
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Figure 2. Resistance-promoting cells are present in both the Ly-24+ 
and the Ly-24- subset of lymphocytes from uninfected mice. On day 0, 
four or five BALB/c nude mice were injected i.d. with 2 x 1<1 promas-
tigotes of L. major and i.p. with LNC from uninfected euthymic 
BALB/c m.ice wbich were either unselected (1<1, 6) or bad been sepa-
rated into the Ly-24+ (e) and Ly-24- (0) subsets by sorting in the 
F ACS and were given in numbers equivalent to their original propor-
tion in 1()6 unselected cells. Control mice received promastigotes alone 
(X). Arithmetic means of the cutaneous lesion scores are given for 
certain time points and the number of mice with lesions relative to the 
total number of mice/group as weil as SE are given for the last time 
point. 
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and Ly-24- cells from normal BALB/c mice could transfer 
protective immunity as efficiently as unseparated cells. Since 
previous studies bave documented that total resistance in 
reconstituted nude mice is promoted by L3T4+ cells only (28), 
it can be concluded that bost-protective cells occur amongst 
both L3T4+ Ly-24+ and L3T4+ Ly-24- T cells. 
3.3 Eft'ect of Ly-2.4+ and Ly-24- cells from chronlcally infected 
BALB/c mice on BALB/c: nude mice reconstituted with 
normal BALB/c lymphoc:ytes 
In cantrast to lymphocytes from uninfected euthymic mice, 
lymphoid cells from euthymic BALB/c mice chronically 
infected with L. major parasites generally fail to induce resis-
tance in BALB/c nude mice. Moreover, an inoculum of 106 or 
more lymphoid cells from mice with progressive disease totally 
abrogates the proteelive effect of lOS to 107 normal mouse 
lympbocytes and this disease-promoting activity has been 
shown tobe mediated by L3T4+ T cells ((5) and Moll, unpub-
lished Observations). Todetermine whether disease-promot-
ing cells are represented in both the Ly-24+ and the Ly-24-
population, we separated these cells by FACS sorting and 
injected them into nude mice that were reconstituted with 
unseparated lymphocytes from uninfected mice at the same 
time. 
As a source of disease-promoting cells, LNC were obtained 
from euthymic BALB/c mice with cbronic disease and large 
cutaneous lesions of score 3. These cells were stained by treat-
ment with anti-Ly-24 and anti-Mac-1 antibodies followed by 
FITC-conjugated anti-lg. As described above, Ly-24- cells 
and Ly-24+ T cells could be clearly distinguished from B cells 
and macropbages and were collected separately. For injection 
into nude mice, 5 x Hf unseparated SC and LNC from unin-
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Figure 3. Disease-promoting cells can be found in the Ly-24+ subset 
but not in the Ly-24- subset of lymphocytes from chronically infected 
mice. On day 0, four to six BALB/c nude mice were injected i.d. with 
2 x 1()6 L. major promastigotes and i.p. with 5 x tOS normal BALB/c 
lymphocytes alone (~) or together with lymphocytes from BALB/c 
m.ice chronically infected with L. major. The latter were either 
unselected (1<1, .&) or separated into the Ly-24+ (e) and Ly-24· (0) 
subsets by F ACS sorting and were given in numbers equivalent to 
their original proportion in 1e1 unselected cells. Control mice received 
promastigotes alone (X). Arithmetic means of the cutaneous lesion 
scores are given for certain time points and the number of mice with 
lesions relative to the total number of m.ice/group as weil as the SE are 
given for the last time point. 
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fected euthymic BALB/c mice were mixed with sorted Ly-24+ 
or Ly-24- cells from infected mice in numbers equivalent to 
their original proportion in 106 unseparated cells. The nude 
mouse recipients were subsequently challenged with 2 x l(f 
L. major promastigotes and the course of cutaneous lesion 
development was determined. The data in Fig. 3 show that 
5 X lOS normal mouse lymphocytes induced resistance to 
cutaneous disease and that a mixture of these cells and unsepa-
rated cells from diseased mice was not protective. Further-
m9re, it can be seen that the disease-promoting activity of 
lymphocytes from chronically infected mice resided in the 
Ly-24+ population, whereas Ly-24- cells failed to abrogate the 
host-protective effect of normal mouse lymphocytes. 
3.4 Expression of Ly-24 on LNC from BALB/c mice chronically 
lnfected with L. mqjor 
In the adoptive transfer experiments using lymphocyte subsets 
from chronically infected mice, disease-promoting cells could 
only be detected in the Ly-24+ population. It was, therefore, 
of interest to examine whether Ly-24 expression was increased 
in BALB/c mice with late-stage cutaneous disease and with a 
very efficient resistance-inhibiting activity, as compared to 
uninfected mice which can give rise to resistance-promoting 
activity. Forthis experiment, we used euthymic BALB/c mice 
that bad been infected with L. major for 3 months and showed 
severe cutaneous lesions -(score 3 to 4). Lymphocytes were 
obtained from the inguinal LN that drain the lesion site and 
were analyzed by two-color immunofluorescence after staining 
with anti-Ly-24 and either anti-L3T4 or anti-Ly-2 antibodies. 
a; 
c 
c 
a 
ö 
Ii 
a. 
== 
..3 
100 • 
150 
CIH 
L3T4+ 
Green Ftuorescence ( Ly-24) 
CJM 
Ly-2• 
Green Ftuorescence ( Ly-24) 
NM 
L3T4+ 
100 1000 
1000 
Figure 4. Ly-24 expression in L3T4+ and Ly-2+ lymphocytes from 
chronically infected mice. Inguinal LNC from uninfected BALB/c 
mice (NM) or from BALB/c mice chronically infected (CIM) with 
L. major were stained with anti-Ly-24 antibodies and either anti-L3T4 
or anti-Ly-2 antiborlies and were subjected to two-coJor fluorescence 
anaJysis in the FACS. The profiles show the Ly-24 expression by 
L3T4+ or Ly-r cells (solid lines). Controls were stained with anti-
L3T4 or anti-Ly-2 aJone (dotted lines). 
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As a control, LNC from uninfected euthymic BALB/c mice 
were treated in the same way. 
The results show (Fig. 4) that · Ly-24 expression was signifi-
cantly increased in both the L3T4+ population and the Ly-2+ 
population of T cells from chronically infected mice. The 
increase in Ly-24 expressionwas more pronounced in L3T4+ 
cells than in Ly-2+ cells thus suggesting that it is predominantly 
the disease-promoting L3T4+ population that gets activated in 
the course of disease. No increase in Ly-24 expression could be 
found in SC from diseased mice ( data not shown). 
In a similar experiment, we also analyzed Ly-24 expression in 
genetically resistant C57BU6 mice that were either untreated 
or infected with L. major. Miceofthis strain usually develop 
only small cutaneous lesions that heal within 1 to 2 months 
after infection. At the peak of lesion development, there was a 
moderate increase in the proportion of Ly-24+ cells in both the 
L3T4+ and the Ly-2+ population of SC and LNC. However, 
no significant increase in Ly-24 expression could be found 
after healing of lesions (data not shown). 
3.5 Frequency determination of L. major-speclftc precursor 
ceUs ln t lymphocyte subpopulatlons from immunized mice 
A LD system was established to estimate the frequency of 
L. major-specific precursor cells in different T lymphocyte 
subpopulations. We observed that T cells from mice infected 
with live parasites showed in vitro responses independent of 
the presence of antigen in culture. However, when respander 
cells were obtained · from mice that bad received several 
immunizations with UV-inactivated L. major parasites, anti-
gen-specific T cell responses could be detected. Limiting num-
bers ofT lymphocytes were stimulated in vitro with an optimal 
concentration of the same parasite antigen preparation and 
accessory cells in the presence of Con ASN. As a control, a 
second series of limiting dilution cultures was set up in the 
absence of antigen for each responder cell population. For 
detection of L. major-reactive T cells, the lymphokine produc-
tion after restimulation of 7-day-old cultures was found tobe 
much more antigen-specific and gave considerably lower back-
ground activity than lymphoproliferation. Hence, SN from 
individual microcultures were split and assayed for IL 2 and 
IL 3 activity as a read-out system for LD analysis. 
T cell Subpopulations were prepared either by cytotoxic treat-
ment (anti-Ly-2.2 antibodies and complement) of nylon wool-
purified T cells, to obtain L3T4+ lymphocytes, or by FACS 
sorting, to obtain Ly-24+ and Ly-24- subsets of L3T4+ lym-
phocytes after a two-color staining procedure. Table 1 sum-
marizes the frequencies (f) of L. major-specific precursor cells 
in various T lymphocyte Subpopulations from immunized or 
untreated C57BU6 or BALB/c mice. The data demoostrate 
that in vivo immunization with L. major antigen resulted in a 
dramatic increase of the frequency of L. major-specific T cells 
(f = 1/4950, as compared to f = 1/80000-1/357000 in untreated 
mice) with antigen-reactive cells being enriched in the L3T4+ 
subpopulation (f = 1/1516 -1/3472). For individual cell popula-
tions, frequencies based on IL 2 production werein the same 
range as those based on IL 3 production but the values were 
generally somewhat higher in C57BU6 than in BALB/c mice. 
Correlation of the two lymphokine activities showed that vir-
tually all microcultures with IL 2 activity also contained IL 3 
and some additional cultures contained IL 3 only ( data not 
shown). 
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Table 1. Frequency of L. major-specific precursor T cells8> 
Treatment of Cell population Reciprocal of precursor frequency 
mice (95% confidence Iimits) 
C51BU6 BALB/c 
IL 2 IL 3 IL 2 IL 3 
Immunized T 4950 NDbl ND ND 
(3865-7rr77) 
L3T4+ 2271 1516 3453 3472 
(1770-3167) (1172-2145) (2577-5230) (2592-4995) 
L3T4+Ly-24+ 1598 648 2962 2282 
(1522-1682) (622-677) (2260-4299) (1690-3533) 
L3T4+Ly-24- 35842 13263 ND ND 
(35258-40322) (12 438-14 205) 
None T 82550 ND ND ND 
(47170-263158) 
L3T4+ 80000 357000 80645 116280 
(42 735-162500) (181800-995 900) ( 48 780-232 560) (68490-384610) 
a) LD analysis of precursor T cells with potential for IL 2 or IL 3 production in C57BU6 or BALB/c mice which were either unprimed or bad 
been immunized with 2 x 107 UV-irradiated L. major promastigotes three times at weekly intervals. Five days after the last immunization, 
T cell Subpopulations were prepared either by treatment with anti-Ly-2.2 antibodies and complement, to obtain L3T4+ lymphocytes, or by 
two-color FACS sorting, to obtain Ly-24+ and Ly-24- subsets of L3T4+ lymphocytes. Limiting numbers ofT cells were cultured with 
syngeneic accessory cells in the presence or absence of L. major antigen and were restimulated 7 days later. After 24 h SN from individual 
cultures were tested for IL 2 and IL 3 activity and minimal estimates of the precursor frequency were obtained by the maximum likelihood 
method. 
b) ND= Not determined. 
l3T4 • cells I well 
6000 
The collection of L3T4+ subsets defined with Ly-24 was not 
useful for cells from immunized BALB/c mice, since over 90% 
of the L3T4+ cells from these mice were Ly-24+. In L. major-
sensitized C57BU6 mice, the proportion of Ly-24 + cells was 
60o/o-70%. This difference in Ly-24 expression between 
BALB/c and C57BU6 mice was recently also reported for nor-
mal mice [25]. Tbe frequency data obtained with T cells from 
immunized C57BU6 mice (Table 1 and Fig. 5) demonstrated 
that L. major-specific lymphocytes were about 20-fold 
enriched in the Ly-24+ subset as compared to the Ly-24- sub-
set of L3T4+ cells. These data from an in vitro culture system 
confirmed the results obtained from in vivo analysis and show 
that the vast majority of L. major-reactive L3T4+ T cells in 
immunized miceexpress the Ly-24 marker. 
4 Discussion 
In murine cutaneous Ieishmaniasis, resistance to disease can 
be mediated by L3T4+ cells from uninfected mice. On the 
Figure 5. Comparison of frequencies of L. major-
specific precursor T cells with the potential for produc-
tion of IL 2 (A) and IL 3 (8) in L3T4+ Ly-24+ (e) and 
L3T4+Ly-24- (0) Subpopulations obtained from 
L. major-immune C57/BL6 mice. Each point is the 
mean of values from two experiments. 
other band, L3T4 + cells from genetically susceptible mice 
chronically infected with L. major are able to abrogate resis-
tance and restore permissiveness to disease. Using a cell titra-
tion approach, previous studies have shown that both types of 
T lymphocytes (resistance-promoting and disease-promoting) 
can in fact be detected in uninfected mice of genetically sus-
ceptible genotypes [29) and in infected mice of genetically sus-
ceptible as weil as genetically resistant mice [30], the propor-
tion of the two functionally distinct cell populations being 
different in each case and determining the outcome of disease. 
The data are compatible with the notion that resistance-pro-
moting T cells are of high frequency in uninfected mice rela-
tive to disease-promoting T cells butthat this ratio is reversed 
in chronically infected mice. Since both T cell types are L3T4+ 
Ly-2- and cannot to date be distinguished on the basis of 
surface marker expression, their isolation and functional 
characterization has not been possible. 
The present study describes an attempt to subdivide L3T4+ 
cells according to the expression of additional cell surface anti-
gens, an approach that led to the identification of functionally 
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diverse subsets in human T4+ cells (31-34). Several markers 
were found tobe expressed by a subset of L3T4 + SC and LNC, 
including the alloantigens Ly-6 [26] and Ly-24 [12) and the 
lymphocyte homing antigen MEL-14 [27]. Transfer of the vari-
ous subsets of L3T4+ defined with these markers from either 
uninfected mice or mice chronically infected with L. major 
parasites, showed that only Ly-24 could split the resistance-
promoting and the disease-promoting activities. 
Using lymphocytes from unlnfected BALB/c mice, both the 
Ly-24- and the Ly-24+ Subpopulations were able to establish 
resistance to L. major infection in otherwise susceptible nude 
mice. Since the studies of Budd et al. (10) suggested that Ly-24 
acquisition in vivo is concomitant with primary antigenic 
stimulation, Ly-24+ cells in untreated mice presumably repre-
sent a pool of T lymphocytes activated by immunization to 
environmental antigens. Resting T cells lacking the Ly-24 anti-
gen, on the other band, probably received their primary anti-
genic stimulus upon encounter of L. major antigens in the 
nude mouse host. The fact that this stimulation resulted in the 
emergence of resistance-promoting activity is in line with the 
notion that, in uninfected mice, the majority of L. major-reac-
tive lymphocytes gives rise to this function. Although it is not 
known whether the Ly-24+ and Ly-24- subsets of L3T4+ cells 
have different activation requirements, the populations can be 
equally stimulated to mediate resistance to cutaneous disease 
since the development of lesions in the nude recipients showed 
a similar time course. 
Using lymphocytes from mice chronically infected with L. ma-
jor only Ly-24+ cells but not Ly-24- cells could abrogate the 
resistance-promoting effect of normal mouse lymphocytes. It 
is likely that chronic disease with large concentrations of para-
site antigen present induced the activation and expansion of 
L. major-specific disease-promoting cells in the genetically 
susceptible donor mice, these cells being represented in the 
Ly-24+ subset. lt is not clear whether the Ly-24+ cells still have 
resistance-promoting activity, now masked by the expanded 
. disease-promoting activity. The Ly-24- population in these 
mice presumably comprises resting lymphocytes with irrele-
vant specificities that do not affect the host-protective activity 
of normal mouse lymphocytes, all L. major-reactive cells hav-
ing been activated. This was confirmed by the inability of Ly-
24- cells from chronically infected donors to alter the outcome 
of cutaneous disease in nude recipients, i.e., these lympho-
cytes exhibited neither disease-promoting nor resistance-
promoting activity (Moll, unpublished data). 
The conclusions drawn from the adoptive transfer experiment 
are supported by the finding that Ly-24 expression is highly 
increased in L3T4+ cells from chronically infected BALB/c 
mice and that this increase is confined to cells from the LN 
draining the site of lesion where large amounts of L. major 
antigen are present. Furthermore, in vitro LD analysis using 
T lymphocyte Subpopulations from mice immunized with 
L. major confirmed that the vast majority of L. major-reac-
tive L3T4+ Tcells express the Ly-24 marker. For these experi-
ments, mice were immunized with a preparation of killed para-
sites since T cells from mice infected with live parasites showed 
in vitro responses independent of the presence of antigen in 
culture. It must be emphasized that the injection regime used 
results in proteelive immunization of the lymphocyte donors. 
The cells responding in culture, therefore, are probably not 
disease-promoting cells. However, we have no idea of the rela-
tive ability of the disease-promoting and resistance-promoting 
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cells to respond in vitro, so this remains an assumption. In the 
same LD system, Ly-2+ cells from L. major-immune mice, 
though capable of lymphokine production upon mitogenic 
stimulus, fail to show any activity in response to L. major 
antigen (Moll, unpublished data). 
The results described in the present study are in agreement 
with recent reports by others [10, 25] showing that Ly-24 
expressed by peripheral T lymphocytes is a marker for anti-
gen-stimulated (memory?) T cells. Furthermore, the present 
data extend this notion to L3T4+ T lymphocytes with func-
tional activity in an in vivo infectious disease model. The only 
other report of highly increased expression of Ly-24 in an 
immunopathological situation deals with autoimmune lprllpr 
mice [351, where most lymphocytes in the peripherallymphoid 
tissues have the unusual phenotype Ly-2- L3T4-. 
With respect to the functionally distinct L3T4+ subpopulations 
that determine the outcome of L. major infections, it should 
be noted that expression of the Ly-24 surface marker per se 
does not distinguish resistance-promoting and disease-promot-
ing T cells since, in lymphoid organs from uninfected mice, 
both the Ly-24- and the Ly-24+ subset can mediate resistance. 
Therefore activation alone (assuming all Ly-24+ cells have 
been previously activated) is not sufficient to generate disease-
promoting activity. In mice chronically infected with L. major, 
on the other band, Ly-24 can be regarded as a marker for 
lymphocytes with the capacity of abrogating resistance to dis-
ease, these cells being activated and expanding in the course of 
progressive infection. Ly-24 is thus not a marker identifying 
distinct lineages of L3T4 + lymphocytes but an antigen ex-
pressed as a result of antigenic stimulation. Expression of Ly-
24 is independent of DNA synthesis and the majority of 
peripheral Ly-24+ T cells are in the Go/G1 phase of the cell 
cycle [11, 36) showing that Ly-24 is not merely a marker of 
actively dividing cells. Although the function of the Ly-24 gly-
coprotein is not known, Ly-24 expression provides an 
extremely useful tool for phenotypic identification and seJec-
tive enrichment of antigen-activated and possibly memory T 
cells. This may facilitate the study of immunopathological pro-
cesses in the course of L. major infection and, most impor-
tantly, the isolation of L. major-specific T cell clones with 
defined activities. 
lt has been suggested that the functionally different types of 
T cells involved in the immune response to L. major belong to 
the same subpopulation and that promotion of either protec-
tion or disease may merely be dependent on the number of 
activated L. major-specific L3T4+ cells present in the host [5, 
37, 38]. According to this hypothesis, small numbers of L3T4 + 
cells would behost protective, whereas excessive numbers of 
the same cell type would have adetrimental effect. However, 
there is increasing evidence supporting the alternative possibil-
ity that resistance to disease or its abrogation are induced by 
distinct subsets of L3T4+ cells [8, 39, 40]. In particular, a 
recent study by Locksley et al. [8] has provided direct evidence 
for differences in lymphokine production by lymphocytes from 
healer and those from nonhealer mice infected with L. major. 
The findings are consistent with the interpretation that inabil-
ity to control cutaneous disease is reflected by expansion of 
type 2 T helper cells (TH2), whereas effective cellular immun-
ity is accompanied by expansion of type 1 T helper cells (THl}. 
However, this classification of L3T4 + subsets [7) is based on 
studies with long-term cultured and cloned murine T cells and 
its validity for fresbly isolated lymphocytes has yet to be con-
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firmed. Moreover, not all T cell clones fit into the T 8 1 and T 8 2 
groups ((41] and Anne Kelso, personal communication) and, 
in the human system, equivalent types of T h cells cannot be 
detected. To date, there is no cell surface marker for phenoty-
pic distinction of the two types of T cells in the mouse but 
recent evidence suggests that rat T cells can be phenotypically 
subdivided into functionally similar subsets [42]. 
Finally, the possibility exists that L3T4 + cells mediating resis-
tance to cutaneous leishmaniasis and L3T4+ cells promoting 
disease differ in antigen specificity rather than in surface 
marker expression (43]. This concept is supported by the find-
ing that a lipophosphoglycan (LPG) isolated from L. mtJjor 
induces resistance to Ieishmania! infection [44), whereas a car-
bohydrate (CHO) produced by enzymatic cleavage of the 
same LPG can exacerbate subsequent disease [45]. lt is con-
ceivable that LPG-specific L3T4+ cells activate L. major-
infected macrophages for killing of intracellular organisms, 
resulting in the resolution of disease, whereas activation of 
CHO-specific L3T4+ cells may result in further inflammation 
and recruitment of immature macrophages that serve as 
targets of infection [46]. The implication of this modelisthat 
different antigens or classes of antigens activate T cells with 
quite different functions, a point that has a precedent in the 
case ofT cells being MHC class I or class II restricted. 
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